Popular Articles

Tighter Controls On Cold And Flu Remedies Help Fight Against Class A Drugs
Cold and flu remedies containing pseudoephedrine and ephedrine will remain as pharmacy (P) medicines after tighter controls were found to minimise the misuse of these ingredients in the illegal manufacture of methylamphetamine (crystal meth).
generic viagra online
Amarillo Biosciences Announces Completion Of Screening Process For Influenza Study In Australia
Amarillo Biosciences, Inc. (ABI) (OTCBB: AMAR) announced that the screening of volunteers for inclusion in a Phase 2 clinical study of the company"s oral interferon product at the University of Western Australia is now complete. The investigators met their target of screening at least 200 healthy adults for participation in the trial. A total of 215 volunteers were evaluated and 134 of them have been enrolled into the study to date. About 90% of the screened subjects have been found to qualify for the study, so additional enrollments are expected over the next 2 weeks to bring the total number of study participants up to or above the targeted 160 subjects.
News of the day
Breast Cancer On The Latest Cancer Waiting Times Stats, Released Today
Dr Alexis Willett, Head of Policy & Involvement at Breakthrough Breast Cancer, says:
Cardiovascular

Live Procedure Webcast: InterStim(R) Testing Procedure For Treatment Of Urinary Disorders

More than 35 million Americans suffer from bladder control problems at some time in their lives. Those suffering from uncontrollable bladder may experience unexpected urine leakage, frequent bathroom use, or have the feeling of not being able to completely empty the bladder. Many people experience a combination of these symptoms. Although it is more common in older adults, and more likely to occur in women than men, it can affect anyone. For many of these people the last hope is an implantable device known as InterStim® Therapy, which was designed to stimulate communication between the brain and bladder to better control urinary incontinence and retention. Before the device can be implanted, however, doctors must perform a test procedure to determine if it will be effective. At 4 p.m. on May 20, 2009, this test procedure will be performed live over the Internet from Tampa General Hospital. The test involves placing a thin wire near the tailbone, which is connected to a small stimulator worn on a belt. The stimulator sends mild electrical pulses through the thin wire to the sacral nerves that control the bladder and muscles related to urinary function. The test is an outpatient procedure typically completed in less than an hour. The patient is placed under a local anesthetic. After the procedure, the patient keeps a journal for a period ranging from five to ten days. If the electrical pulses result in an increase in proper bladder function, the patient may proceed to the surgical implementation procedure. Raul Ordorica, M.D., Associate Professor, Division of Urology, University of South Florida College of Medicine, will perform the procedure to test the effectiveness of the InterStim® device. Dr. Ordorica has had extensive experience with InterStim® Therapy since it was FDA approved in 1998, and was the first to perform the implant at Tampa General Hospital. The procedure will be narrated by Mark Swierzewski, M.D., Florida Urology Partners. To view this procedure, log on to http://www.tgh.org and click on the link on the homepage. If you are unable to view the live broadcast, the procedure will be available on demand at http://www.tgh.org and http://www.OR-Live.com for future viewing at your convenience. ORLive


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):